David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Charter Communications
CHTR
$18.2B
| $8.21M | 0.01% |
+23,657
| New | +$7.79M |
|
1202
Freshpet
FRPT
$3.59B
| $8.21M | 0.01% |
194,016
+175,440
| +944% | +$6.75M |
|
1203
PUT
Macy's
M
$6B
| $8.19M | 0.01% |
340,700
-479,300
| -58% | -$12.1M |
|
1204
CALL
Stellantis
STLA
$19.6B
| $8.17M | 0.01% |
550,300
+63,400
| +13% | +$974K |
|
1205
Bausch Health
BHC
$2.47B
| $8.17M | 0.01% |
330,633
-351,113
| -52% | -$8.39M |
|
1206
Corbus Pharmaceuticals
CRBP
$219M
| $8.16M | 0.01% |
39,152
+21,315
| +119% | +$4.7M |
|
1207
Quest Diagnostics
DGX
$27.1B
| $8.14M | 0.01% |
90,512
-272,007
| -75% | -$23.6M |
|
1208
Central Garden & Pet Co Class A
CENTA
$2.39B
| $8.13M | 0.01% |
437,243
-35,996
| -8% | -$865K |
|
1209
Watsco Inc
WSO
$12.9B
| $8.12M | 0.01% |
56,729
+22,838
| +67% | +$3.28M |
|
1210
Keysight
KEYS
$55.4B
| $8.11M | 0.01% |
92,950
-339,497
| -79% | -$26.4M |
|
1211
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
| $8.09M | 0.01% |
+314,817
| New | +$8.13M |
|
1212
CALL
Etsy
ETSY
$7.63B
| $8.07M | 0.01% |
+120,000
| New | +$7.16M |
|
1213
AtriCure
ATRC
$2.42B
| $8.04M | 0.01% |
300,209
+29,294
| +11% | +$890K |
|
1214
PUT
Viatris
VTRS
$19.4B
| $8.02M | 0.01% |
282,800
+16,100
| +6% | +$470K |
|
1215
LivePerson
LPSN
$33.9M
| $7.98M | 0.01% |
18,336
-5,868
| -24% | -$2.2M |
|
1216
OneSpan
OSPN
$563M
| $7.94M | 0.01% |
413,273
+81,182
| +24% | +$1.38M |
|
|
BIG
1217
DELISTED
Big Lots, Inc.
BIG
| $7.93M | 0.01% |
208,626
+151,525
| +265% | +$4.94M |
|
|
SINA
1218
PUT
DELISTED
Sina Corp
SINA
| $7.93M | 0.01% |
133,900
-15,700
| -10% | -$941K |
|
1219
Four Corners Property Trust
FCPT
$2.77B
| $7.93M | 0.01% |
267,912
-104,369
| -28% | -$2.89M |
|
|
SGEN
1220
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.92M | 0.01% |
108,183
+64,218
| +146% | +$4.57M |
|
|
CPLG
1221
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $7.92M | 0.01% |
709,147
-399,155
| -36% | -$5.15M |
|
1222
CALL
3M
MMM
$92.6B
| $7.92M | 0.01% |
45,568
-76,783
| -63% | -$12.9M |
|
|
HRC
1223
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $7.92M | 0.01% |
74,769
-100,342
| -57% | -$10.1M |
|
1224
Gibraltar Industries
ROCK
$1.38B
| $7.91M | 0.01% |
194,812
-42,304
| -18% | -$1.61M |
|
|
PPLI
1225
PUT
People Inc
PPLI
$2.92B
| $7.88M | 0.01% |
209,828
-567,934
| -73% | -$21M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.